This company listing is no longer active
G Medical Innovations Holdings Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Información clave
8.1%
Tasa de crecimiento de los beneficios
46.1%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare | 15.7% |
Tasa de crecimiento de los ingresos | 30.1% |
Rentabilidad financiera | n/a |
Margen neto | -529.8% |
Última actualización de beneficios | 30 Jun 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero G Medical Innovations Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Jun 22 | 4 | -23 | 21 | 2 |
31 Mar 22 | 5 | -19 | 16 | 2 |
31 Dec 21 | 5 | -15 | 11 | 2 |
30 Sep 21 | 5 | -14 | 11 | 1 |
30 Jun 21 | 6 | -12 | 10 | 1 |
31 Mar 21 | 5 | -12 | 10 | 1 |
31 Dec 20 | 5 | -13 | 9 | 1 |
30 Sep 20 | 5 | -13 | 8 | 2 |
30 Jun 20 | 5 | -13 | 8 | 2 |
31 Mar 20 | 5 | -14 | 9 | 2 |
31 Dec 19 | 6 | -15 | 10 | 3 |
30 Sep 19 | 5 | -15 | 11 | 3 |
30 Jun 19 | 5 | -15 | 12 | 3 |
31 Mar 19 | 4 | -15 | 13 | 4 |
31 Dec 18 | 3 | -16 | 13 | 4 |
30 Sep 18 | 2 | -15 | 11 | 5 |
30 Jun 18 | 1 | -14 | 9 | 5 |
31 Mar 18 | 1 | -20 | 16 | 4 |
31 Dec 17 | 0 | -27 | 23 | 4 |
30 Sep 17 | 0 | -26 | 21 | 3 |
30 Jun 17 | 0 | -24 | 20 | 3 |
31 Mar 17 | 0 | -13 | 11 | 2 |
31 Dec 16 | 0 | -3 | 1 | 2 |
Ingresos de calidad: 9GM0 is currently unprofitable.
Margen de beneficios creciente: 9GM0 is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 9GM0 is unprofitable, but has reduced losses over the past 5 years at a rate of 8.1% per year.
Acelerando crecimiento: Unable to compare 9GM0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: 9GM0 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-28.6%).
Rentabilidad financiera
Alta ROE: 9GM0's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.